Literature DB >> 7614482

Mutation frequency of the p16/CDKN2 gene in primary cancers in the upper digestive tract.

H Igaki1, H Sasaki, Y Tachimori, H Kato, H Watanabe, T Kimura, Y Harada, T Sugimura, M Terada.   

Abstract

We report a highly frequent homozygous deletion of the p16/CDKN2 gene in the esophageal cancer cell line and a relatively high frequency of homozygous deletion in gastric cancer cell lines. In contrast, in primary esophageal carcinomas, mutation frequency of the p16/CDKN2 gene has been controversial (0, 21, and 52% previously reported), and no reports are available for the mutation frequency of this gene in surgical specimens of gastric carcinomas. Here we report that four (16%) of 25 primary esophageal squamous cell carcinomas were found to be mutated, one in exon 1 and three in exon 2, and that no mutations were observed in 19 surgical specimens of gastric adenocarcinomas. This is the first report showing the absence or quite low frequency of mutation in surgical specimens of gastric carcinomas.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7614482

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  8 in total

Review 1.  The CDKN2A (p16) gene and human cancer.

Authors:  W D Foulkes; T Y Flanders; P M Pollock; N K Hayward
Journal:  Mol Med       Date:  1997-01       Impact factor: 6.354

2.  Characterization of oncogene suppressor marker expression in patients with submucosal gastric carcinoma.

Authors:  Roberson A Moron; Carlos Eduardo Jacob; Claudio José Caldas Bresciani; Kleber Simões; Venâncio Avancini Ferreira Alves; Kyoshi Irya; Joaquim Gama-Rodrigues; Ivan Cecconello; Adhemar Longatto-Filho; Bruno Zilberstein
Journal:  Mol Clin Oncol       Date:  2017-12-29

3.  Methylation, a major mechanism of p16/CDKN2 gene inactivation in head and neck squamous carcinoma.

Authors:  A K El-Naggar; S Lai; G Clayman; J K Lee; M A Luna; H Goepfert; J G Batsakis
Journal:  Am J Pathol       Date:  1997-12       Impact factor: 4.307

4.  Epstein-barr virus-positive gastric carcinoma demonstrates frequent aberrant methylation of multiple genes and constitutes CpG island methylator phenotype-positive gastric carcinoma.

Authors:  Gyeong Hoon Kang; Sun Lee; Woo Ho Kim; Hye Won Lee; Jin Cheon Kim; Mun-Gan Rhyu; Jae Y Ro
Journal:  Am J Pathol       Date:  2002-03       Impact factor: 4.307

5.  p16/CDKN2 alterations and pRb expression in oesophageal squamous carcinoma.

Authors:  G Busatto; Y H Shiao; A R Parenti; R Baffa; A Ruol; M Plebani; M Rugge
Journal:  Mol Pathol       Date:  1998-04

6.  Methylation and mutation analysis of p16 gene in gastric cancer.

Authors:  Yi Ding; Xiao-Ping Le; Qin-Xian Zhang; Peng Du
Journal:  World J Gastroenterol       Date:  2003-03       Impact factor: 5.742

7.  Epstein-Barr virus in gastric adenocarcinomas: association with ethnicity and CDKN2A promoter methylation.

Authors:  Q N Vo; J Geradts; M L Gulley; D A Boudreau; J C Bravo; B G Schneider
Journal:  J Clin Pathol       Date:  2002-09       Impact factor: 3.411

8.  Intragenic homozygous deletions of MTS1 gene in gastric cancer in Taiwan.

Authors:  M S Wu; Y W Lin; J C Sheu; H P Wang; J T Wang; C T Shun; W J Lee; T H Wang; J T Lin
Journal:  Jpn J Cancer Res       Date:  1996-10
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.